Inventiva IVA
NASDAQ IVA
$3.55 +0.29 (+8.90%)
At close: Oct 21, 2026 · 4:00 PM EDT

Inventiva (IVA) EBIT Margin (2020 - 2021)

Updated

Inventiva (IVA) posted EBIT Margin of -3145.51% for FY2025, down 2084.86 percentage points from -1060.64% in FY2024.

Analysis

Inventiva (IVA) EBIT Margin (2020 - 2021) Analysis & Trends

Since FY2018, Inventiva has reported EBIT Margin for 8 years.

  • Annual EBIT Margin has declined for three consecutive years, though with a five-year change of +4843.20 percentage points (FY2020 to FY2025).
  • The FY2025 figure stands as the lowest annual EBIT Margin since FY2020.
  • Business Quant data shows IVA's EBIT Margin at -1060.64% in FY2024 (-472.96 pp), -587.68% in FY2023 (-118.76 pp), -468.92% in FY2022 (+773.66 pp) and -1242.58% in FY2021 (+6746.13 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Inventiva 665.95 Mn -164.50 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -21,021.54%
Mar 31, 2021 -13,435.14%
Jun 30, 2020 -11,972.97%
Mar 31, 2020 -7,821.84%
API Access

Inventiva EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=IVA&period=max&api_key=YOUR_API_KEY